[脂肪肝疾病的重命名对药物临床试验的影响]
1Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on Non-Alcoholic Fatty Liver Disease (NAFLD) Diagnosis, Beijing 100044, China.
概括
代谢功能障碍相关的脂肪肝病 (MASLD) 现在取代了非酒精性脂肪肝病,扩大了其定义. 这一变化影响了临床试验和患者选择脂肪肝疾病治疗的方法.
科学领域:
- 肝病学和代谢疾病研究.
背景情况:
- 脂肪肝疾病已被更名为代谢功能障碍相关的脂肪肝疾病 (MASLD).
- 以前的定义要求排除其他肝脏疾病,这已经被删除了.
- 现在,MASLD的定义是与代谢功能障碍或特定酒精消耗水平相关的肝肥胖症.
研究的目的:
- 引入代谢功能障碍相关的脂肪肝疾病 (MASLD) 的新定义.
- 突出新分类对临床研究和患者分层的影响.
主要方法:
- 对脂肪肝疾病的更新诊断标准的审查和分析.
- 将新的MASLD定义与以前的非酒精性脂肪性肝病 (NAFLD) 标准进行比较.
主要成果:
- 非酒精性脂肪性肝病 (NAFLD) 的术语被代谢功能障碍相关的脂肪性肝病 (MASLD) 取代.
- MASLD定义包括超重/肥胖,2型糖尿病或代谢障碍,以及定义的酒精限量.
- 引入了新的术语,如代谢相关的酒精性肝病和密码性脂肪性肝病.
结论:
- 改名为MASLD意味着转向将代谢功能障碍视为主要驱动因素.
- 这些定义变化需要调整临床试验设计和确定治疗干预的患者队列.
- 更新后的框架为脂肪肝疾病的研究和有针对性的治疗策略提供了新的机会.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
136
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
136
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Drug Biotransformation: Overview
2.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.5K
Hepatic Drug Excretion: Influencing Factors
152
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
152
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
696
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
696


